High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery
- Conditions
- Respiratory FailureChronic Obstructive Pulmonary Disease
- Interventions
- Combination Product: CONTROLCombination Product: High flow nasal cannula
- Registration Number
- NCT04520568
- Lead Sponsor
- Alexandria University
- Brief Summary
High-flow nasal cannula (HFNC) is a device that delivers10 to 70 L min-1 of heated, humidified 100% oxygen via nasal route. It provides positive airway pressure, decreases dyspnea, decreases the work of breathing, and improves comfort
- Detailed Description
Beneficial effects of the HFNC system have been assessed based on 3 physiologic conditions: decreased dead space, a high concentration of inspiratory oxygen, and positive pressure in the oro-laryngeal cavity.Studies have shown that it improves oxygenation in various perioperative settings such as the apneic patients, patients with respiratory failure , and patients undergoing bronchoscopy
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
- ASA physical status II and III,
- undergoing VATS
- refusal of patients
- extrem of age
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description control group CONTROL induction of general anaesthesia will be done using 2 mg/kg propofol and 1 µg/kg fentanyl. Double lumen tube will be facilitated by cisatracurium 0.2 mg/kg. Anaesthesia will be maintained with isoflurane 0.8 %-1% in 100% oxygen and maintenance dose of cisatracurium 0.02 mg/kg when needed. At the end of surgery, residual neuromuscular paralysis will be antagonized with neostigmine 0.05 mg/kg and atropine 0.01 mg/kg. HFNC group High flow nasal cannula For HFNC group, F\&P AIRVOTM 2 will be adjusted to give the patients the oxygen flow at 50L/min and the FiO2 at 1.0.Then after three minutes of preoxygenation, sedation will be conducted by giving 25 µg fentanyl and a bolus of 1 mg/kg propofol followed by continuous infusion of propofol using a target-controlled infusion system (TCI pump TE371; Terumo Corporation, TokyoJapan).
- Primary Outcome Measures
Name Time Method arterial partial pressures of oxygen two hours an arterial blood sample will be taken after induction of anaesthesia then every 10 min till the end of the operation.
pH measurement two hours an arterial blood sample will be taken after induction of anaesthesia then every 10 min till the end of the operation.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rehab Abd Elraof Abd Elaziz
🇪🇬Alexandria, Egypt